Cblb-deficient T cells are less susceptible to PD-L1-mediated inhibition
Sign Up to like & getrecommendations! Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.18360
Abstract: Modulation of the immune system for the treatment of primary and metastatic tumors has been a goal of cancer research for many years. The E3 ubiquitin ligase Cbl-b has been established as an intracellular checkpoint… read more here.
Keywords: susceptible mediated; deficient cells; cblb deficient; less susceptible ... See more keywords